Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2013 4
2014 3
2015 6
2016 4
2017 11
2018 16
2019 24
2020 10
2021 17
2022 21
2023 17
2024 25
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

142 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for talat bessissow
Search for talat bessisow instead (1 results)
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease.
Peyrin-Biroulet L, Chapman JC, Colombel JF, Caprioli F, D'Haens G, Ferrante M, Schreiber S, Atreya R, Danese S, Lindsay JO, Bossuyt P, Siegmund B, Irving PM, Panaccione R, Cao Q, Neimark E, Wallace K, Anschutz T, Kligys K, Duan WR, Pivorunas V, Huang X, Berg S, Shu L, Dubinsky M; SEQUENCE Study Group. Peyrin-Biroulet L, et al. N Engl J Med. 2024 Jul 18;391(3):213-223. doi: 10.1056/NEJMoa2314585. N Engl J Med. 2024. PMID: 39018531 Clinical Trial.
Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials.
Louis E, Schreiber S, Panaccione R, Bossuyt P, Biedermann L, Colombel JF, Parkes G, Peyrin-Biroulet L, D'Haens G, Hisamatsu T, Siegmund B, Wu K, Boland BS, Melmed GY, Armuzzi A, Levine P, Kalabic J, Chen S, Cheng L, Shu L, Duan WR, Pivorunas V, Sanchez Gonzalez Y, D'Cunha R, Neimark E, Wallace K, Atreya R, Ferrante M, Loftus EV Jr; INSPIRE and COMMAND Study Group. Louis E, et al. JAMA. 2024 Sep 17;332(11):881-897. doi: 10.1001/jama.2024.12414. JAMA. 2024. PMID: 39037800 Clinical Trial.
Comparative Efficacy of Advanced Therapies for Achieving Endoscopic Outcomes in Crohn's Disease: A Systematic Review and Network Meta-Analysis.
Vuyyuru SK, Nguyen TM, Murad MH, Narula N, Bessissow T, Zou G, McCurdy JD, Peyrin-Biroulet L, Danese S, Ma C, Singh S, Jairath V. Vuyyuru SK, et al. Among authors: bessissow t. Clin Gastroenterol Hepatol. 2024 Jun;22(6):1190-1199.e15. doi: 10.1016/j.cgh.2023.12.023. Epub 2024 Jan 6. Clin Gastroenterol Hepatol. 2024. PMID: 38185396
Isolated Small Bowel Amyloidosis.
Ghaith J, Mukhtar M, Bessissow T. Ghaith J, et al. Among authors: bessissow t. J Can Assoc Gastroenterol. 2021 Aug 13;5(6):249-250. doi: 10.1093/jcag/gwab026. eCollection 2022 Dec. J Can Assoc Gastroenterol. 2021. PMID: 36467601 Free PMC article. No abstract available.
Endoscopic management of Crohn's strictures.
Bessissow T, Reinglas J, Aruljothy A, Lakatos PL, Van Assche G. Bessissow T, et al. World J Gastroenterol. 2018 May 7;24(17):1859-1867. doi: 10.3748/wjg.v24.i17.1859. World J Gastroenterol. 2018. PMID: 29740201 Free PMC article. Review.
Vedolizumab-Associated Hypereosinophilia and Hepatoxicity.
De Marco D, Bessissow T, Marcus V, Benmassaoud A. De Marco D, et al. Among authors: bessissow t. ACG Case Rep J. 2022 Nov 16;9(11):e00905. doi: 10.14309/crj.0000000000000905. eCollection 2022 Nov. ACG Case Rep J. 2022. PMID: 36404891 Free PMC article.
142 results